Efficacy of infliximab in treatment on inflammatory bowel disease and factors affecting the therapeutic effect
10.3969/j.issn.1673-4254.2013.12.28
- VernacularTitle:英夫利昔单抗治疗炎症性肠病的疗效及影响因素分析
- Author:
Youlian ZHOU
1
;
Ye CHEN
Author Information
1. 南方医科大学南方医院消化科
- Keywords:
infliximab;
inflammatory bowel disease;
efficacy;
influencing factors
- From:
Journal of Southern Medical University
2013;(12):1833-1838
- CountryChina
- Language:Chinese
-
Abstract:
Objective Infliximab has shown its superiority and safety in the treatment of inflammatory bowel disease (IBD) that failed to respond to traditional medical therapy, in refractory cases with obvious adverse reactions, and in"top-down therapy". For standardized and effective management of IBD, experts worldwide have consecutively issued the 2010 European ECCO guide, 2011 London consensus, and 2012 Chinese consensus. In this paper, based on the latest expert consensus worldwide, we reviewed the efficacy of infliximab treatment on IBD and the factors affecting its therapeutic effect.
